MJBizDaily
Forget the DEA and DOJ: When cannabis legalization happens, these are the feds to worry about
Featured
Latest Posts
Cannabis businesses not immune from vaccine-mandate controversy
Vaccine mandates aren’t popular among cannabis employers, most of whom are too small to face government directives.
News December 16How Curaleaf deal could shape marijuana debt financing
Curaleaf deal sets bar higher for marijuana debt financing, and investor interest in environmental, social and governance (ESG) policies.
News December 15Marijuana REIT tops 100 properties with $72 million deal
Real estate investment trust Innovative Industrial Properties said it acquired a portfolio of 27 cannabis properties in Colorado, North Dakota and Pennsylvania for $72.7 million excluding transaction costs.
News December 15Private-sector online cannabis sales, delivery coming to Alberta in March
Private-sector cannabis retailers in Alberta will take over online adult-use sales and delivery from a government-owned online store in March 2022, providing new opportunities to stores in the competitive Canadian…
News December 15Marijuana Policy Project appoints ex-Illinois lawmaker as president, CEO
One of the nation's foremost cannabis activist groups, the Marijuana Policy Project (MPP), on Wednesday announced it has chosen former Illinois state Sen. Toi Hutchinson as its new president and…
News December 15Colorado adds to list of approved pesticides for cannabis growers
Colorado regulators are allowing four more pesticides to be used in cannabis cultivation.
News December 15Oregon lawmakers earmark $25 million to combat illicit marijuana grows
Oregon lawmakers set aside $25 million to crack down on illegal marijuana grows, which have become a major issue in the state.
News December 15Washington state’s cannabis traceability system begins with bumpy rollout
Washington state is rolling out its own marijuana seed-to-sale traceability system after having relied on the private sector for years, but so far, the government-run platform's debut this month has…
News December 15German pharma firm Dermapharm buying Canopy’s cannabinoid subsidiary C3
German pharmaceutical manufacturer Dermapharm Holding SE has struck a deal to buy C3 Cannabinoid Compound Co. GmbH from Canadian cannabis producer Canopy Growth.
News December 15












